- Continued Revenue Strength and Yield Improvement -
“We had another strong quarter supported by growth in our military and
commercial business as we deepened our penetration both in the U.S. and
abroad. As a result of efforts to expand our revenue base, we are seeing
significant interest globally in our technology with 57% of our revenues
this quarter outside the U.S. Total revenues in the third quarter were
“On the military side of the business, our momentum is continuing as evidenced by several new program wins, reinforcing the value of our cutting-edge technology. In addition, we continue to successfully execute on a number of existing key domestic and foreign military programs. Earlier this year we participated in the DefExpo18 show to capitalize on India’s rapid market expansion and I am pleased to report that we now have five new Indian customers.
“On the commercial front, we are seeing expanded interest from established medical device companies to incorporate our microdisplays into their products. These applications include viewing devices for cataract surgery and for transmitting images to MRI patients. We also received orders in the quarter from an existing medical device customer to upgrade their equipment as well as from a new customer who will be incorporating our displays into equipment used for a variety of surgical applications.
During the quarter, we achieved design approval from one of our Tier 1 consumer electronics partners. This design meets the wide field of view, no screen door effect and high brightness afforded by our patented Direct Patterning (“dPd”) technology that our partner requires. Our foundry partner for consumer applications will be manufacturing wafers for the display prototypes.
“Overall, our discussions with consumer electronics partners are ongoing and productive as we advance our cutting-edge product to meet the demanding performance requirements for this market. We are in dialogue with potential mass production and licensing partners to ensure that we will have manufacturing capacity sufficient for the consumer electronics end market. In concert with our consumer activities, we are actively working on improvements to our dPd technology and upgrading our custom dPd production equipment. We anticipate that these upgrades will increase product yields, lower unit costs, and significantly extend display lifetime.
“Our backlog at the end of September for the next 12 months was
Business and Product Highlights
-
We received a
$780 thousand order from an existing medical device customer upgrading their product with our high brightness XLT technology. These displays are scheduled for delivery over the next twelve months with anticipated follow-on orders. - We continued to expand our presence in the medical field with the second order from a new customer that is developing/prototyping a non-invasive surgical application device using our displays. This customer anticipates bringing these systems to market in early 2019.
- We are progressing with the OLED upgrade to a production helmet for a multi-service, multi-country, fixed wing aircraft program. Our OLED displays will be replacing the LCD displays currently employed in these helmets. Displays required for Initial Operational Capability are scheduled to begin shipping in the fourth quarter as we progress towards Limited Rate Initial Production (LRIP).
-
We received an order totaling
$400 thousand in support of the Javelin Missile program Command Launch Unit (CLU). A follow-on order worth$560 thousand is anticipated in the fourth quarter. Separately, we received our third order for displays for the Javelin trainers. -
We continue to ship on the U.S. Army Enhanced Night Vision Goggle
(ENVG-III) program and are providing additional engineering support
for the Binocular (ENVG-B) program. This program is anticipated to
commence production in 2019 with an overall acquisition objective by
the
U.S. Army of 190,000 systems. -
We delivered final displays to support a major
U.S. Army helicopter helmet upgrade program to retrofit high brightness microdisplays into the current fielded helmet in preparation for scheduled ground and flight tests. - We received a follow-on contract for the Family of Weapon Sight – Individual (FWS-I) program following the delivery of displays for the LRIP phase of the program late last year. We are currently in the process of finalizing another follow-on contract for the FWS-I.
- In September we signed a long-term agreement with a major French Defense Contractor to supply all their microdisplays for their weapons products and helmets.
- We delivered the first 2K x 2K compact board interface to an aviation prime for the development of a next generation helmet prototype.
-
We received three new awards in July from the
U.S. Army totaling$545 thousand to improve OLED production yields and expand capacity. Total awards to date under this project are$830 thousand and having are an impact on our production performance.
Quarter Results
Revenues for the third quarter of 2018 grew 60% to
Product revenues increased in the quarter by 51% to
Overall gross margin for the third quarter was 35% compared to 7% in the prior year period. The increase in gross margin was primarily due to increased volumes and higher yields, resulting in lower costs per displays, as well as the addition of several military related contracts at favorable margins. The 2017 third quarter was impacted by production issues which were subsequently resolved.
Operating expenses for the third quarter of 2018, including R&D
expenses, were
Operating loss for the third quarter was
Other income for the third quarter was
Net income for the third quarter of 2018, inclusive of the
Non-GAAP Adjusted EBITDA for the quarter was negative
As of
Conference Call Information
A conference call and live webcast will begin today at
About
A leader in OLED microdisplay technology, OLED microdisplay manufacturing know-how and mobile display systems, eMagin manufactures high-resolution OLED microdisplays and integrates them with magnifying optics to deliver virtual images comparable to large-screen computer and television displays in portable, low-power, lightweight personal displays. eMagin’s microdisplays provide near-eye imagery in a variety of products from military, industrial, medical and consumer OEMs. More information about eMagin is available at www.emagin.com.
Forward-Looking Statements
This press release contains forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933 and Section 21E of
the Securities Exchange Act of 1934, including those regarding eMagin
Corporation’s expectations, intentions, strategies and beliefs
pertaining to future events or future financial performance. Actual
events or results may differ materially from those in the
forward-looking statements as a result of various important factors,
including those described in the Company’s most recent filings with the
Non-GAAP Financial Measures
To supplement the Company’s consolidated financial statements presented on a GAAP basis, the Company has provided non-GAAP financial information, namely earnings before interest, taxes, depreciation and amortization, and non-cash compensation expense (“Adjusted EBITDA”). The Company’s management believes that this non-GAAP measure provides investors with a better understanding of how the results relate to the Company’s historical performance. The additional adjusted information is not meant to be considered in isolation or as a substitute for GAAP financial statements. Management believes that these adjusted measures reflect the essential operating activities of the Company. A reconciliation of non-GAAP financial information appears below.
| EMAGIN CORPORATION | ||||||||
| CONSOLIDATED BALANCE SHEETS | ||||||||
| (in thousands, except share and per share data) | ||||||||
|
(unaudited) |
||||||||
| September 30, | December 31, | |||||||
| 2018 | 2017 | |||||||
|
|
||||||||
| ASSETS | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents | $ | 6,190 | $ | 3,526 | ||||
| Accounts receivable, net | 4,381 | 4,528 | ||||||
| Unbilled accounts receivable | 364 | 406 | ||||||
| Inventories | 8,719 | 8,640 | ||||||
| Prepaid expenses and other current assets | 869 | 1,328 | ||||||
| Total current assets | 20,523 | 18,428 | ||||||
| Equipment, furniture and leasehold improvements, net | 8,567 | 8,553 | ||||||
| Intangibles and other assets | 314 | 326 | ||||||
| Total assets | $ | 29,404 | $ | 27,307 | ||||
| LIABILITIES AND SHAREHOLDERS’ EQUITY | ||||||||
| Current liabilities: | ||||||||
| Accounts payable | $ | 1,996 | $ | 1,714 | ||||
| Accrued compensation | 1,436 | 1,557 | ||||||
| Revolving credit facility, net | — | 3,808 | ||||||
| Common stock warrant liability | 3,303 | 784 | ||||||
| Other accrued expenses | 1,909 | 719 | ||||||
| Deferred revenue | 41 | 765 | ||||||
| Other current liabilities | 389 | 469 | ||||||
| Total current liabilities | 9,074 | 9,816 | ||||||
| Commitments and contingencies (Note 9) | ||||||||
| Shareholders’ equity: | ||||||||
| Preferred stock, $.001 par value: authorized 10,000,000 shares: | ||||||||
| Series B Convertible Preferred stock, (liquidation preference of $5,659) stated value $1,000 per share, $.001 par value: 10,000 shares designated and 5,659 issued and outstanding as of September 30, 2018 and December 31, 2017 | — | — | ||||||
| Common stock, $.001 par value: authorized 200,000,000 shares, issued 45,323,339 shares, outstanding 45,161,273 shares as of September 30, 2018 and issued 35,182,589 shares, outstanding 35,020,523 shares as of December 31, 2017 | 45 | 35 | ||||||
| Additional paid-in capital | 254,638 | 244,726 | ||||||
| Accumulated deficit | (233,853 | ) | (226,770 | ) | ||||
| Treasury stock, 162,066 shares as of September 30, 2018 and December 31, 2017 | (500 | ) | (500 | ) | ||||
| Total shareholders’ equity | 20,330 | 17,491 | ||||||
| Total liabilities and shareholders’ equity | $ | 29,404 | $ | 27,307 | ||||
| EMAGIN CORPORATION | ||||||||||||||||
| CONSOLIDATED STATEMENTS OF OPERATIONS | ||||||||||||||||
| (in thousands, except share and per share data) | ||||||||||||||||
| (unaudited) | ||||||||||||||||
| Three Months Ended | Nine Months Ended | |||||||||||||||
| September 30, | September 30, | |||||||||||||||
| 2018 | 2017 | 2018 | 2017 | |||||||||||||
| Revenues: | ||||||||||||||||
| Product | $ | 6,048 | $ | 4,014 | $ | 18,127 | $ | 13,050 | ||||||||
| Contract | 819 | 266 | 2,673 | 2,559 | ||||||||||||
| Total revenues, net | 6,867 | 4,280 | 20,800 | 15,609 | ||||||||||||
| Cost of revenues: | ||||||||||||||||
| Product | 3,926 | 3,802 | 12,256 | 10,918 | ||||||||||||
| Contract | 562 | 200 | 1,389 | 1,346 | ||||||||||||
| Impairment of Consumer Night Vision inventory | — | — | 2,690 | — | ||||||||||||
| Total cost of revenues | 4,488 | 4,002 | 16,335 | 12,264 | ||||||||||||
| Gross profit | 2,379 | 278 | 4,465 | 3,345 | ||||||||||||
| Operating expenses: | ||||||||||||||||
| Research and development | 1,590 | 1,271 | 4,941 | 3,782 | ||||||||||||
| Selling, general and administrative | 2,039 | 1,970 | 6,982 | 6,586 | ||||||||||||
| Total operating expenses | 3,629 | 3,241 | 11,923 | 10,368 | ||||||||||||
| Loss from operations | (1,250 | ) | (2,963 | ) | (7,458 | ) | (7,023 | ) | ||||||||
| Other income (expense): | ||||||||||||||||
| Change in fair value of common stock warrant liability | 1,311 | — | 387 | — | ||||||||||||
| Interest expense, net | 1 | (27 | ) | (12 | ) | (249 | ) | |||||||||
| Other income, net | 1 | (2 | ) | — | 11 | |||||||||||
| Total other income (expense) | 1,313 | (29 | ) | 375 | (238 | ) | ||||||||||
| Income (loss) before provision for income taxes | 63 | (2,992 | ) | (7,083 | ) | (7,261 | ) | |||||||||
| (Provision) benefit for income taxes | — | — | — | — | ||||||||||||
| Net income (loss) | $ | 63 | $ | (2,992 | ) | $ | (7,083 | ) | $ | (7,261 | ) | |||||
| Less net income allocated to participating securities | 9 | — | — | — | ||||||||||||
| Net income (loss) allocated to common shares | $ | 54 | $ | (2,992 | ) | $ | (7,083 | ) | $ | (7,261 | ) | |||||
| Loss per share, basic | $ | 0.00 | $ | (0.09 | ) | $ | (0.16 | ) | $ | (0.22 | ) | |||||
| Loss per share, diluted | $ | 0.00 | $ | (0.09 | ) | $ | (0.16 | ) | $ | (0.22 | ) | |||||
| Weighted average number of shares outstanding: | ||||||||||||||||
| Basic | 45,149,717 | 34,972,589 | 44,182,379 | 33,214,262 | ||||||||||||
| Diluted | 45,265,370 | 34,972,589 | 44,182,379 | 33,214,262 | ||||||||||||
|
Non-GAAP Information |
||||||||||||||||
| Three Months Ended | Nine Months Ended | |||||||||||||||
| September 30, | September 30, | |||||||||||||||
| 2018 | 2017 | 2018 | 2017 | |||||||||||||
| Net income (loss) | $ | 63 | $ | (2,992 | ) | $ | (7,083 | ) | $ | (7,261 | ) | |||||
| Non-cash compensation | 177 | 190 | 512 | 520 | ||||||||||||
| Change in fair value of common stock warrant liability | (1,311 | ) | — | (387 | ) | — | ||||||||||
| Depreciation and intangibles amortization expense | 470 | 395 | 1,420 | 1,376 | ||||||||||||
| Interest expense | 34 | 26 | 106 | 249 | ||||||||||||
| Provision for income taxes | — | — | — | — | ||||||||||||
| Adjusted EBITDA | $ | (567 | ) | $ | (2,381 | ) | $ | (5,432 | ) | $ | (5,116 | ) | ||||
View source version on businesswire.com: https://www.businesswire.com/news/home/20181108005140/en/
Source:
eMagin Corporation
Jeffrey Lucas, President and Chief Financial
Officer
845-838-7931
This email address is being protected from spambots. You need JavaScript enabled to view it.
or
Affinity
Growth Advisors
Betsy Brod
212-661-2231
This email address is being protected from spambots. You need JavaScript enabled to view it.